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Abstract
Background: Xuesaitong (XST) injection, consisting of total saponins from Panax notoginseng, was widely used for
the treatment of cardio- and cerebro-vascular diseases in China. This study develops a simple and global quality
evaluation method for the quality control of XST.
Methods: High performance liquid chromatography-ultraviolet detection (HPLC-UV) was used to identify and
quantify the chromatographic fingerprints of the XST injection. Characteristic common peaks were identified using
HPLC with photo diode array detection/electrospray ionization tandem mass spectrometry (HPLC-PDA/ESI-MS
n).
Results: Representative fingerprints from ten batches of samples showed 27 ‘common saponins’ all of which were
identified and quantified using ten reference saponins.
Conclusion: Chemical fingerprinting and quantitative analysis identified most of the common saponins for the
quality control of P. notoginseng products such as the XST injection.
Background
Xuesaitong (XST) injection, consisting of total saponins
from Panax notoginseng (Sanqi), was widely used for the
treatment of cardiovascular and cerebrovascular diseases
in China. As total saponins (including ginsenosides and
notoginsenosides) in the XST injection are its active
ingredients, quality control of total saponins in the XST
injection is critical for its safety, efficacy and stability.
Single or simultaneous determination of main compo-
nents of the total saponin extracts from P. notoginseng
using high performance liquid chromatography-ultravio-
let detection (HPLC-UV) [1-5], high performance liquid
chromatography-evaporative light scattering detection
(HPLC-ELSD) [6], high performance liquid chromato-
graphy-mass spectroscopy (HPLC-MS) [7-13] have been
reported but over half of the total saponins were not
quantified in these studies due to the lack of saponin
references or poor chromatographic resolution. A com-
prehensive and systematic quality control of saponin
extracts is much needed.
F i n g e r p r i n ta n a l y s i si sc u r r e ntly developed for quality
control in Chinese medicine [14-26] and has been
accepted by the WHO for the assessment of herbal medi-
cines [27]. The State Food and Drug Administration
(SFDA) of China requires all herbal medicine-derived
injections and related materials to use chromatographic
fingerprints [28] in standardization.
This article reports a novel fingerprint analytical method
for quality control of the XST injection, which may be
applicable to other herbal products. Over the previous stu-
dies [1-13], the new method features the following advan-
tages. (1) The representative fingerprints show good
chromatographic separation for most of visible peaks in
the chromatographic profiles at 203 nm; (2) All main
saponins (27 visible peaks in chromatographic profiles) are
identifiable using high performance liquid chromatogra-
phy-photo diode array detection/electrospray ionization
tandem mass spectrometry (HPLC-PDA/ESI-MS
n)t e c h n i -
que, ten saponin references or data from literature [8-14].
Methods
Materials and reagents
Acetonitrile and methanol (HPLC grade) were pur-
chased from Merck (Darmstadt, Germany). Acetic acid
* Correspondence: fanxh@zju.edu.cn
Pharmaceutical Informatics Institute, Zhejiang University, Hangzhou 310058,
China
Yao et al. Chinese Medicine 2011, 6:9
http://www.cmjournal.org/content/6/1/9
© 2011 Yao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.glacial (HPLC grade) was from Tedia (Fairfield, OH,
USA). The water used was purified by Milli-Q system
(Millipore, USA). Reference compounds, namely noto-
ginsenoside R1,g i n s e n o s i d eR g 1,R g 2,R h 1,R b 1,R b 2,R d ,
Re, 20(S)-Rg3 and 20(R)-Rg3 were purchased from Jilin
University (Shenyang, China). The structures of these
compounds are shown in Figure 1. Mixed standard
stock solution containing accurately weighed reference
compounds was directly prepared in 80% aqueous
methanol (v/v). Working standard solutions were pre-
pared by diluting the stock solution with 80% aqueous
methanol (v/v) to obtain a series of concentrations for
the calibration curves.
HPLC instrumentationadditional 1 and chromatographic
conditions
An Agilent 1100 HPLC system (Agilent Technologies,
USA) consisted of a quaternary solvent delivery system,
an on-line degasser, an auto-sampler, a column tem-
perature controller and ultraviolet detector coupled with
an analytical workstation and an Ultimate™ XB-C18 col-
umn, 5 μm, 250 mm × 4.6 mm i.d. (Welch Materials,
USA) were used in the HPLC-UV experiments. Flow
rate was 1.0 ml/min and sample injection volume was
10 μl. Detection wavelength was set at 203 nm and the
column temperature was at 30°C. Mobile phase con-
tained deionized water-acetic acid (A; 100:0.01, v/v) and
acetonitrile-acetic acid (B; 100:0.01, v/v). The gradient
elution was as follows: 19-21.2% B at 0-30 min; 21.2-
26% B at 30-35 min; 26-28% B at 35-40 min; 28-38% B
at 40-50 min; 38-55% B at 50-60 min; 55% B at 60-65
min; 55-80% B at 65-70 min; 80-95% B at 70-75 min.
Re-equilibrium was 10 min; the total run time was
85 min.
HPLC-MS
n instrumentation and chromatographic
conditions
Analysis was performed on an Agilent 1100 series LC
system equipped with a binary solvent delivery system,
an auto-sampler, a column temperature controller, a
photo diode array detector and a Finnigan LCQ Deca
XP
plus ion trap mass spectrometer (Thermo Finnigan,
USA) via an ESI interface. The chromatographic condi-
tions were the same for HPLC-UV as described in the
previous section. The operating parameters for MS in
t h en e g a t i v em o d ew e r ea sf o l l o w s :c o l l i s i o ng a s ,u l t r a -
high-purity helium (He); nebulizing gas, high purity
nitrogen (N2); ion spray voltage, -4.5 kV; sheath gas
(N2) at a flow rate of 60 arbitrary units; auxiliary gas
(N2) at a flow rate of 20 arbitrary units; capillary tem-
perature, 350°C; capillary voltage, -15 V; tube lens offset
voltage, -30 V. Full scan data acquisition was performed
from m/z 80 to 1800 in MS scan mode. The MS
n spec-
tra were obtained with the collision energy for collision-
induced dissociation adjusted to 30%-40% of maximum
and the isolation width of precursor ions was 2.0Th.
Sample preparation
Ten samples of the XST injection (Batch No. 20090307,
20090510, 20090310, 20081018, 9042213, 20090312,
20090421, 20090512, 20090504, 20090203), manufac-
tured by three Chinese pharmaceutical companies, were
obtained either from pharmacies or factories. For
HPLC-PDA-MS
n analysis, a certain volume of the injec-
tion, according to its nominal content of total saponins,
was transferred to a 50 ml volumetric flask and was
diluted with 80% aqueous methanol (v/v) to obtain total
saponins at a concentration of about 1 mg/ml. For
HPLC-UV analysis, the injection was diluted with 80%
aqueous methanol (v/v) to obtain total saponins at a
concentration of about 0.5 mg/ml. Prior to analysis, the
sample solutions were filtered through a 0.45 μmn y l o n
membrane (Whatman, Britain). Spiked injection was
produced by mixing sample solutions with the reference
solutions at the ratio of 1:1.
Data analysis
Data analysis was carried out with Similarity Evaluation
System for Chromatographic Fingerprint of Traditional
Chinese Medicine (version 2004A, National Committee
of Pharmacopoeia, China) recommended by the SFDA.
Results and discussion
Optimization of HPLC separation
We optimized the separation conditions including the
column, mobile phase, detection wavelength, elution
gradient and column temperature in this study. Four
reversed-phase columns, Agilent Zorbax Eclipse SB-C18
columns (250 mm × 4.6 mm, 5 μm; 150 mm × 4.6 mm,
3.5 μm; 100 mm × 2.1 mm, 1.8 μm) and Ultimate™
XB-C18 column (250 mm × 4.6 mm, 5 μm) were tested.
The results showed that all four columns obtained good
peak resolutions in 75 min, 75 min, 45 min and 75 min
respectively; however, only two columns with the length
of 250 mm (Zorbax Eclipse SB-C18 and Ultimate™ XB-
C18) produced more peaks in chromatograms. Ulti-
mate™ XB-C18 column (250 mm × 4.6 mm, 5 μm) was
selected in the fingerprint analysis due to its lower cost
than Zorbax Eclipse SB-C18 column.
The effects of mobile phase composition on chroma-
tographic separation were also studied. The cetonitrile/
water system produced more sharp peaks than the
methanol/water system; the addition of 0.01% acetic
acid in the acetonitrile/water system further improved
the peak shape. Moreover, as the retention time of some
components such as ginsenoside 20(S)-Rg3 and 20(R)-
Rg3 was long, gradient elution was used in HPLC analy-
sis. Satisfactory separation was achieved in 75 min.
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Page 2 of 8There was no strong absorption for most of saponins
in the region of ultraviolet and visible spectra due to
their structural characteristics, eg lack of conjugation
groups in the molecular structures. As the end adsorp-
tion wavelength 203 nm is suitable for the assay of
ginsenosides and notoginsenosides [1-5], it was selected
as the detection wavelength in the experiment. Further-
more, the effects of column temperature on chromato-
graphic separation were also examined. Four column
temperatures, namely 20, 25, 30 and 35°C were tested.
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 No.  Saponin  R1 R 2 R 3 
20S-form 1  Notoginsenoside  R3 OH  Oglc  Oglc(6-1)-glc 
2 Notoginsenoside  R1 OH  Oglc(2-1)xyl  Oglc 
3 Ginsenoside  Rg1 OH  Oglc  Oglc 
4 Ginsenoside  Re  OH  Oglc(2-1)rha  Oglc 
5 Notoginsenoside  R6 OH  Oglc  Oglc(6-1)-glc' 
6 Ginsenoside  Rf  OH  Oglc(2-1)glc  OH 
7 Notoginsenoside  I 
* OH  Oglc(2-1)glc  Oglc(6-1)glc 
8 SC1 
** OH  Oxyl  Oglc(6-1)xyl 
9 Ginsenoside  Rg2 OH  Oglc(2-1)rha  OH 
10 Ginsenoside  Rh1 OH  Oglc  OH 
11 Ginsenoside  F1 OH  OH  Oglc 
12 Notoginsenoside  R4 Oglc(2-1)glc  H  Oglc(6-1)glc(6-1)xyl 
13 Notoginsenoside  Fa  Oglc(2-1)glc(2-1)xyl  H  Oglc(6-1)glc 
14 Ginsenoside  Rb1 Oglc(2-1)glc  H  Oglc(6-1)glc 
15 Notoginsenoside  Fc  Oglc(2-1)glc(2-1)xyl  H  Oglc(6-1)xyl 
16 Ginsenoside  Rb2 Oglc(2-1)glc  H  Oglc(6-1)araf 
17 Ginsenoside  Rd  Oglc(2-1)glc  H  Oglc 
18 Notoginsenoside  K  Oglc(6-1)glc  H  Oglc 
19 Ginsenoside  F2 Oglc  H  Oglc 
20 Ginsenoside  20(S)-Rg3 Oglc(2-1)glc  H  OH 
20R-form 21  Ginsenoside  20(R)-Rg3 Oglc(2-1)glc H  OH 
20(21)-ene-form 22 Notoginsenoside  T5 OH  OGlc(3-1)xyl  – 
23 Ginsenoside  Rk1 Oglc(2-1)glc  H  – 
24 Ginsenosiede  Rk3   OH  Oglc  – 
20(22)-ene-form 25 Ginsenosiede  Rh4   OH  Oglc  – 
26 Ginsenoside  Rg5 Oglc(2-1)glc  H  – 
Figure 1 Structures of the investigated saponins in P. notoginseng.g l c ,b-D-glucose; glc’, a-D-glucosexyl, b-D-xylose; rha, a-L-rhamnose;
araf, a-L-arabinose (furanose). Notoginsenoside I *, H is instead of OH (C12) in 20S-form. SC1 **, 6-O-b-D-xylopyranosyl -20-b-D-xylopyranosyl-
(1®6)-b-D-glucopyranosyl dammar-24-ene-3b,6 a,1 2 b, 20(S)tetraol.
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Page 3 of 8We found that at 30°C most peaks in chromatography
had good resolutions; therefore, 30°C was chosen as the
column temperature for the fingerprint analysis.
HPLC-UV fingerprinting of the XST injection
To standardize the fingerprints, we analyzed ten samples
using the optimized HPLC-UV method. Peaks found in
all ten samples with good resolution were assigned as
‘characteristic peaks’ and there were 27 characteristic
peaks in the fingerprint chromatograms (Figure 2A). The
software of Similarity Evaluation System for Chromato-
graphic Fingerprint of Traditional Chinese Medicine was
used to evaluate these chroma t o g r a m s .T oe x c l u d et h e
effects of the solvent and baseline fluctuation, we selected
the chromatographic data of these ten samples and trea-
ted them within the time frame of 28 min to 75 min. The
similarities of chromatograms for the ten samples to the
reference fingerprints were established using the means
of all chromatograms (Additional file 1). The results
showed that the ten samples possessed similarities to the
reference fingerprints (Additional file 2). While the
HPLC-UV fingerprints from different batches and com-
panies varied, the 27 characteristic peaks were common
in all samples. Therefore, the detection of these common
peaks in HPLC fingerprints is useful in assessing the
quality of the XST injection.
Identification of characteristic peaks
HPLC-PDA/ESI-MS
n was used for the components analy-
sis and all 27 characteristic peaks were identified. In the
ESI-MS experiment, the molecular weight of each peak was
also obtained. By comparing with the ESI-MS
n data and
HPLC retention time of standard sanponins (Figure 2B and
Additional file 3), we identified 10 peaks as notogisenoside
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Figure 2 Chromatograms of (A) the representative fingerprint, (B) mixture standard compounds including (1) notoginsenoside R1,
(2) ginsenoside Rg1, (3) ginsenoside Re, (9) ginsenoside Rb1, (11) ginsenoside Rg2, (12) ginsenoside Rh1, (13) ginsenoside Rb2, (15),
ginsenoside Rd, (23) ginsenoside 20 (S)-Rg3 and (24) ginsenoside 20 (R)-Rg3.
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Page 4 of 8R1, ginsenoside Rg1, Re, Rb1,R g 2,R h 1,R b 2, Rd and 20(S)-
Rg3,2 0 ( R ) - R g 3. A total of 17 peaks were identified tenta-
tively with the aid of the ESI-MS
n data and HPLC retention
time of some saponins from previous reports [1-13]. All the
identification results are shown in Table 1. In addition, The
UV spectra of all peaks in the XST injection were obtained
from the PDA chromatogram (Additional file 3). The
results showed that among all the peaks in the chromato-
gram of the XST injection no strong UV absorption within
the wavelength range from 210 nm to 400 nm was
obtained, suggesting that the XST injection consisted of
saponins with few other natural components possessing
strong UV absorption, such as flavonoids, lignins, anthra-
quinones and alkaloids.
Determination of the main saponins in the XST injection
As shown in Figure 2A, 27 saponins were well separated,
of which 25 were potentially identified (Table 1). The ratio
of total saponin peak area to all peaks (except for solvent
peaks and baseline fluctuation in 0-28 min) in the
chromatogram of each sample was beyond 95%. Thus, a
method for quantification of the 27 saponins should pro-
vide a global and systematical evaluation for the quality
control of the XST injection. However, it was difficult to
obtain the reference compounds for all 27 saponins; we
were only able to obtain ten, including notoginsenoside
R1, ginsenoside Rg1, Re, Rb1,R g 2,R h 1,R b 2, Rd, 20(S)-Rg3
and 20(R)-Rg3. Some reports [1-3] found that the slopes of
regression equations for most of the determined saponins,
such as notoginsenoside R2,R 4, Fa, ginsenoside Rg1,R e ,
Rf, Rb1,R g 2,R h 1 and Rd were approximately negatively
correlated to their molecular weights by HPLC-UV at 203
nm (Additional file 4) and that the regression equations of
some saponins with similar molecular weights were also
close to each other under the same chromatographic con-
dition (Additional file 5, 6, 7, 8 and 9).
Ten saponins, namely R1, ginsenoside Rg1, Re, Rb1,R g 2,
Rh1,R b 2, Rd, 20(S)-Rg3 and 20(R)-Rg3 were quantitatively
determined and the rest 17 saponins without standard
references were semi-quantified using substitutive
Table 1 The identification results of saponins in the XST injection by LC/MS
n
Peak
No.
Identification Retention time
(min)
MS[M-H]
- MS data (m/z)
1 Notoginsenoside R1 34.89 932 799 [M-H-Xyl]
-; 637 [M-H-Xyl-Glc]
-; 475 Agl
2 Ginsenoside Rg1 39.32 800 637 [M-H-Glc]
-; 619 [M-H-H2O-Glc]
-; 475 Agl
3 Ginsenoside Re 39.72 945 783 [M-H-Glc]
-; 637 [M-H-Glc-Rha]
-; 475 Agl
4 Notoginsenoside R4 51.24 1240 1107 [M-H-Xyl]
-; 1077 [M-H-Glc]]
-; 945 [M-H-Xyl-Glc; 783 [M-H-Xyl-2Glc]
-
5 Ginsenoside Rf 51.89 800 637 [M-H-Glc]]
-; 475 Agl
6 Notoginsenoside Fa 52.17 1240 1107 [M-H-Xyl]
-; 1077 [M-H-Glc]]
-; 945 [M-H-Xyl-Glc; 783 [M-H-Xyl-2Glc]
-
7 Notoginsenoside I 52.39 1092 929[M-H-Glc]
-; 767 [M-H-2Glc]
-; 605[M-H-3Glc]
-
8 SC1 52.56 901 769 [M-H-Xyl]
-; 637 [M-H-2Xyl]
-; 475 Agl
9 Ginsenoside Rb1 53.48 1107 945 [M-H-Glc]
-; 783 [M-H-2Glc]
-; 621 [M-H-3Glc]
-; 459 Agl
10 Notoginsenoside Fc 54.32 1209 1077 [M-H-Xyl]
-; 945 [M-H-2Xyl]
-; 783 [M-H-2Xyl-Glc]
-; 621 [M-H-2Xyl-2Glc]
-
; 459 Agl
11 Ginsenoside Rg2 54.75 783 637 [M-H-Rha]
-; 621 [M-H-Glc]
-; 475 Agl
12 Ginsenoside Rh1 55.04 637 475 [M-H-Glc]
-
13 Ginsenoside Rb2 55.30 1077 945[M-H-Arap]
-; 915[M-H-Glc]
-; 783[M-HArap-Glc]
-; 621[M-H-Arap-2Glc]
-;
459 Agl
14 Ginsenoside F1 55.84 637 475 [M-H-Glc]
-
15 Ginsenoside Rd 57.16 945 783 [M-H-Glc]
-; 621[M-H-2Glc]
-; 459Agl
16 Notoginsenoside K 58.32 945 783 [M-H-Glc]
-; 621[M-H-2Glc]
-; 459Agl
17 Notoginsenoside T5/
Unkown
61.70 752 619[M-H-Xyl]
-; 457 Agl
18 Unkown 62.09 765 603[M-H-Glc]
-
19 Notoginsenoside T5/
Unkown
62.42 752 619[M-H-Xyl]
-; 457 Agl
20 Unkown 62.81 765 603[M-H-Glc]
-
21 Ginsenoside Rk3 63.42 619 551 [M-H-C5H10]
-
22 Ginsenoside Rh4 64.18 619 551 [M-H-C5H10]
-
23 20(S)-ginsenoside Rg3 65.14 783 621 [M-H-Glc]
-; 459 Agl
24 20(R)-ginsenoside Rg3 65.86 783 621 [M-H-Glc]
-; 459 Agl
25 Ginsenoside F2 66.05 783 621 [M-H-Glc]
-; 459 Agl
26 Ginsenoside Rk1 72.47 765 603 [M-H-Glc]
-
27 Ginsenoside Rg5 72.89 765 603 [M-H-Glc]
-
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Page 5 of 8standard substances. The calibration curves for the quan-
tification of each saponin were selected and listed in
Table 2. The developed analytical method was successfully
applied to analysis of ten batches of the XST injection. All
of the 27 characteristic peaks were determined simulta-
neously and the results are in Table 3. In the XST injec-
tion, the content of ginsenoside Rb1 was the most
(26.17%-29.60%), followed by ginsenoside Rg1 (20.50%-
25.43%), Rd (6.82%-8.10%), notoginsenoside R1 (5.29%-
6.89%) and ginsenoside Re (2.91%-4.92%). The total
content of the five saponins made up 61.69%-71.39% of the
total saponins in the XST injection (total saponins nom-
inal: 50 mg/ml). The ten saponins with available standard
substances were quantitatively determined and made up
68.46%-75.85% of the total saponins nominal. Thus, com-
bined with the semi-quantification data, 81.81%-95.71%
components in the XST injection could be examined.
Conclusion
The fingerprint profiles of ten batches of samples showed
27 characteristic peaks. Ten of these 27 saponins in the
XST injections were quantitatively determined with their
standard references; the rest 17 saponins were semi-
quantified with the substitutive standard references.
Additional material
Additional file 1: The chromatogram of similarity analysis of the
fingerprints of 10 samples.
Additional file 2: The similarities of chromatograms of 10 samples
(n = 3).
Additional file 3: PDA Chromatograms. standard compounds (A) and
a XST injection (C), and total ion current chromatograms of standard
compounds (B) and a XST injection (D). 1-27 were the characteristic
peaks, listed in Table 2
Additional file 4: Plots of slopes of calibration curves vs. molecular
weights (MW) of saponins. From literatures (A) [Journal of
Pharmaceutical and Biomedical Analysis 41 (2006) 274-279], (B) [Journal
of Pharmaceutical and Biomedical Analysis 48 (2008) 1361-1367], (C)
[Journal of Pharmaceutical and Biomedical Analysis 38 (2005) 45-51], (D)
[Journal of Chromatography A 1011 (2003) 77-87], (E) [Journal of
Shenyang Pharmaceutical University Vol. 20, No.1 (2003) 27-31], and (F)
[Chinese Pharmaceutical Journal Vol. 38, No.9 (2003) 698-699]
Additional file 5: The method validation for simultaneous
determination of the twenty-seven saponins in XST injection. The
quantitative and semi-quantitative methods were validated and the
semi-quantitative principle were discussed in detail.
Table 2 Calibration curves, detection limits and quantification limits of the saponins by HPLC-UV
Peak No. Saponins M.W. Calibration curve
a Linear range (μg/ml) R
2 LOD (μg/ml)
21 Ginsenoside Rk3 619 y = 6.7519x - 7.6085
22 Ginsenoside Rh4 619 y = 6.7519x - 7.6085
12 Ginsenoside Rh1 637 y = 6.7519x - 7.6085 4.28-68.5 0.9993 2.14
14 Ginsenoside F1 637 y = 6.7519x - 7.6085
17 Notoginsenoside T5/Unkown 752 y = 5.4845x - 4.8387
19 Notoginsenoside T5/Unkown 752 y = 5.4845x - 4.8387
18 Unkown 765 y = 5.4845x - 4.8387
20 Unkown 765 y = 5.4845x - 4.8387
26 Ginsenoside Rk1 765 y = 5.4845x - 4.8387
27 Ginsenoside Rg5 765 y = 5.4845x - 4.8387
11 Ginsenoside Rg2 783 y = 5.6715x - 5.6679 3.34-53.5 0.9993 1.67
23 20(S)-Rg3 783 y = 5.4845x - 4.8387 2.95-47.3 0.9990 1.48
24 20(R)-Rg3 783 y = 5.0923x - 2.8995 2.63-42.0 0.9994 1.75
25 Ginsenoside F2 783 y = 5.4845x - 4.8387
2 Ginsenoside Rg1 800 y = 5.1367x - 76.471 16.64-1065 0.9990 10.29
5 Ginsenoside Rf 800 y = 5.1367x - 76.471
8 SC1 901 y = 4.3254x - 5.0843
1 Notoginsenoside R1 932 y = 4.3254x - 5.0843 10.26-492.5 0.9997 7.42
3 Ginsenoside Re 945 y = 4.4123x - 29.465 43.28-692.5 0.9993 4.73
15 Ginsenoside Rd 945 y = 4.1199x - 5.5681 16.64-532.5 0.9993 4.43
16 Notoginsenoside K 945 y = 4.1199x - 5.5681
13 Ginsenoside Rb2 1077 y = 3.8757x + 2.4182 4.84-77.5 0.9995 1.95
7 Notoginsenoside I 1092 y = 3.8757x + 2.4182
9 Ginsenoside Rb1 1107 y = 3.5815x - 29.548 15.98-1022.5 0.9992 7.91
10 Notoginsenoside Fc 1209 y = 3.5815x - 29.548
4 Notoginsenoside R4 1240 y = 3.5815x - 29.548
6 Notoginsenoside Fa 1240 y = 3.5815x - 29.548
a y: peak area of analyte; x: concentration of analyte (μg/ml).
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Page 6 of 8Additional file 6: Precisions and repeatability. The results of precision
and repeatability for simultaneous determination of the twenty-seven
saponins
Additional file 7: Recovery. The results of recovery for simultaneous
determination of the twenty-seven saponins
Additional file 8: Plots of slopes of calibration curves vs molecular
weights (MW) with different chromatography columns. (A)
Ultimate™™ XB-C18 (250 mm × 4.6 mm, 5 μm), (B) Zorbax Eclipse SB-
C18 (250 mm × 4.6 mm, 5 μm) and (C) Zorbax Eclipse SB-C18 (100 mm
× 2.1 mm, 1.8 μm)
Additional file 9: Regression equation using different columns.
Columns: Zorbax Eclipse SB-C18 (250 mm × 4.6 mm, 5 μm) and Zorbax
Eclipse SB-C18 (100 mm × 2.1 mm, 1.8 μm)
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